Cargando...
Hydroxychloroquine-induced podocytopathy mimicking Fabry disease
Hydroxychloroquine (HCQ) is largely prescribed as an immunomodulator to prevent systemic diseases flares in patients with systemic lupus erythematous, rheumatoid arthritis, Sjogren’s disease. Among reported side effects, HCQ can accumulate in lysosomes and induced phospholipidosis. Here, we report a...
Guardado en:
| Publicado en: | BMJ Case Rep |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6536225/ https://ncbi.nlm.nih.gov/pubmed/31088818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228876 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|